2007, Number 3
<< Back Next >>
Acta Med 2007; 5 (3)
Inhalated insulin: A new therapeutical weapon for the management of diabetes mellitus
Jiménez SM, Muñoz SA, González BD
Language: Spanish
References: 5
Page: 160-161
PDF size: 54.55 Kb.
Text Extraction
No abstract
REFERENCES
Cefalu WT. Concept, strategies and feasibility of non-invasive insulin delivery. Diabetes Care 2004; 27: 239-246.
Trubo R. Interest in inhaled insulin grows. JAMA 2005; 294: 1195-1196.
Rave K, Bott S, Heinemann L, Sha S et al. Time-action profile of inhaled insulin in comparison with subcutaneously injected insulin lispro and regular human insulin. Diabetes Care 2005; 28: 1077-1082.
Rosenstock J, Zinman B, Murphy LJ, Clement SC, Moore P, Bowering CK et al. Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes. A randomized, controlled trial. Ann Intern Med 2005; 143: 549-558.
Heise T, Bott S, Tusek C, Stephan JA, Kawabata T, Finco-Kent D, Liu C, Krasner A. The effect of insulin antibodies on the metabolic action ob inhaled and subcutaneous insulin. A prospective randomized pharmacodynamic study. Diabetes Care 2005; 28: 2161-2169.
Full text